Literature DB >> 18470624

Association between metabolic effects and tobacco use in 60-year-old Swedish men.

Per Eric Wändell1, Gunilla Bolinder, Ulf de Faire, Mai-Lis Hellénius.   

Abstract

There is a controversy whether use of smokeless tobacco is associated with an increased risk of diabetes. A population-based cross-sectional study was undertaken of 1,859 men, aged 60 years, in Stockholm County. No significant association was found between risk of diabetes and any use of tobacco, even if an association between snuff and risk of diabetes could not be excluded.

Entities:  

Mesh：

Year:  2008        PMID： 18470624     DOI： 10.1007/s10654-008-9260-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  21 in total

1.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  Waist circumference and weight following smoking cessation in a general population: the Inter99 study.

Authors:  Charlotta Pisinger; Torben Jorgensen
Journal:  Prev Med       Date:  2007-01-11       Impact factor: 4.018

3.  Circulatory disease and smokeless tobacco in Western populations: a review of the evidence.

Authors:  Peter N Lee
Journal:  Int J Epidemiol       Date:  2007-06-25       Impact factor: 7.196

4.  Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden.

Authors:  Bengt Haglund; Mats Eliasson; Magnus Stenbeck; Måns Rosén
Journal:  Scand J Public Health       Date:  2007       Impact factor: 3.021

5.  The effect of cigarette smoking on adrenal cortical hormones.

Authors:  J A Baron; R J Comi; V Cryns; T Brinck-Johnsen; N G Mercer
Journal:  J Pharmacol Exp Ther       Date:  1995-01       Impact factor: 4.030

6.  Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing?

Authors:  Margareta Norberg; Hans Stenlund; Bernt Lindahl; Kurt Boman; Lars Weinehall
Journal:  Scand J Public Health       Date:  2006       Impact factor: 3.021

7.  Cigarette smoking, oral moist snuff use and glucose intolerance.

Authors:  P G Persson; S Carlsson; L Svanström; C G Ostenson; S Efendic; V Grill
Journal:  J Intern Med       Date:  2000-08       Impact factor: 8.989

8.  Smokeless tobacco as a possible risk factor for stroke in men: a nested case-control study.

Authors:  Kjell Asplund; Salmir Nasic; Urban Janlert; Birgitta Stegmayr
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

9.  The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking.

Authors:  P Wennberg; M Eliasson; G Hallmans; L Johansson; K Boman; J-H Jansson
Journal:  J Intern Med       Date:  2007-09       Impact factor: 8.989

10.  Nicotine intake and dependence in Swedish snuff takers.

Authors:  H Holm; M J Jarvis; M A Russell; C Feyerabend
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530
View more
  4 in total

Review 1.  Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review.

Authors:  Magdalena Walicka; Cristina Russo; Michael Baxter; Isaac John; Grazia Caci; Riccardo Polosa
Journal:  World J Diabetes       Date:  2022-06-15

2.  Weight gain and incident obesity among male snus users.

Authors:  Jenny Hansson; Maria Rosaria Galanti; Cecilia Magnusson; Maria-Pia Hergens
Journal:  BMC Public Health       Date:  2011-05-23       Impact factor: 3.295

Review 3.  Snus: a compelling harm reduction alternative to cigarettes.

Authors:  Elizabeth Clarke; Keith Thompson; Sarah Weaver; Joseph Thompson; Grant O'Connell
Journal:  Harm Reduct J       Date:  2019-11-27

4.  Cardiovascular risk factors in Assyrians/Syrians and native Swedes with type 2 diabetes: a population-based epidemiological study.

Authors:  Marina Taloyan; Alexandre Wajngot; Sven-Erik Johansson; Jonas Tovi; Jan Sundquist
Journal:  Cardiovasc Diabetol       Date:  2009-11-12       Impact factor: 9.951
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.